Feedback
Make this your Home
News Markets Mutual Funds IPO Commodities Wealth Portfolio Messages Videos Mail CNBC-TV18
CNBC-TV18 Matrix SENSEX 17021.85 236.20 NIFTY 5052.45 63.45
 

GlaxoSmithKline Pharmaceuticals Cash Flow, GlaxoSmithKline Pharmaceuticals Financial Statement & Accounts

GlaxoSmithKline Pharmaceuticals

BSE: 500660  |  NSE: GLAXO  |  ISIN: INE159A01016  |  Pharmaceuticals

Print/Copy to Excel :
« Previous Years  

Cash Flow of GlaxoSmithKline Pharmaceuticals

------------------- in Rs. Cr. -------------------
Dec '04 Dec '05 Dec '06 Dec '07 Dec '08
12 mths 12 mths 12 mths 12 mths 12 mths
Net Profit Before Tax 418.24 477.91 555.95 611.17 679.90
Net Cash From Operating Activities 219.11 344.21 250.51 306.97 319.42
Net Cash (used in)/from
Investing Activities
-132.07 84.10 5.95 111.54 787.30
Net Cash (used in)/from Financing Activities -99.97 -444.03 -269.13 -298.52 -355.31
Net (decrease)/increase In Cash and Cash Equivalents -12.94 -15.73 -12.67 119.99 751.41
Opening Cash & Cash Equivalents 76.32 63.38 47.65 34.98 154.97
Closing Cash & Cash Equivalents 63.38 47.65 34.98 154.97 906.39
Source : Religare Technova
Explore GlaxoSmithKline connections